SCHEMBL9822261

SCHEMBL9822261

CC(O)c1nc2nccc([S])n2n1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SORD Q00796 19/20 0.36
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9822214 0.82 SORD (0.35) SORD
SCHEMBL9822085 0.75 KMT2A (0.37) SORD
SCHEMBL9822245 0.71 MEN1 (0.34)
SCHEMBL9822357 0.71
SCHEMBL9822158 0.69 PKM (0.35) POLB
SCHEMBL9822351 0.67 SORD (0.36) SORDPOLB
SCHEMBL9822185 0.65 KDM4E (0.43) POLB
SCHEMBL9770445 0.63 KMT2A (0.38) SORD
SCHEMBL9822064 0.62 KMT2A (0.37) SORD
SCHEMBL9822277 0.62 LMNA (0.39) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4987129-A BACTERICIDES SANKEI PHARMACEUTICAL CO., LTD. (JP) 1991-01-22 US disclosed
US-4958019-A Intermediates for synthesis of cephalosporin compounds SANKEI PHARMACEUTICAL CO., LTD. (JP) 1990-09-18 US disclosed
US-4956462-A Bactericides, ANTIBIOTICS, CEPHALOSPORINS SANKEI PHARMACEUTICAL CO., LTD. (JP) 1990-09-11 US disclosed
EP-0302633-A2 Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) 1989-02-08 EP disclosed